Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo

 

Get News and Updates

 

eco

CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn

ny

New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

News Releases

PeriRx, LLC Covering All Bases During Its Greater New York Dental Meeting Debut

SaliMark-Branded Box with ReportThe Company’s Launch of Its SaliMark™ OSCC Salivary Test for Oral Cancer Includes Free CE Course, Free Industry Reception, and Free Test Kit

BROOMALL, PA–(Marketwired – Nov 21, 2014) – PeriRx, LLC, a premier developer of breakthrough, non-invasive, oral diagnostic technology, will be making its national debut at booth #1506 during the Greater New York Dental Meeting from Sunday, November 30th to Wednesday, December 3rd at the Jacob K. Javits Convention Center in New York City. [Read more…]

PeriRx LLC’s Robust Product Pipeline Includes Salivary Test for Sjogren’s Syndrome — a Common Symptom of Rheumatoid Arthritis

MarketwireHAVERTOWN, PA–(Marketwired – May 28, 2014) – PeriRx LLC, a premier developer of breakthrough, non-invasive, salivary diagnostic technology, recently announced that it will be introducing a highly accurate and scientifically validated molecular biomarker test for the early detection of Sjögren’s Syndrome by the end of 2014.

Sjögren’s Syndrome is a systemic chronic inflammatory disorder in which the immune system attacks and damages the body’s moisture-producing glands. This causes dryness of the eyes and mouth and is associated with a number of oral and ocular complications. [Read more…]

Coming Soon: PeriRx LLC’s Breakthrough Salivary Test to Aid in the Fight Against Oral Cancer

MarketwireThe World’s Most Clinically Advanced and Scientifically Validated Molecular DNA Biomarker Test for Oral Squamous Cell Carcinoma is Launching in Late Spring

HAVERTOWN, PA–(Marketwired – Apr 3, 2014) – PeriRx LLC, a premier developer of breakthrough, non-invasive, oral diagnostic technology recently announced that it will be introducing the world’s most clinically advanced and scientifically validated molecular DNA biomarker test for oral squamous cell carcinoma detection in the late spring. [Read more…]